Astellas Pharma Inc (ALPMY)

9.79 +0.14 (+1.45%) USD  |  OTCM  |  Dec 20, 16:00
More

Astellas Pharma Max Drawdown (5Y): 44.10% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for ALPMY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Takeda Pharmaceutical Co Ltd 54.24%
Pfizer Inc 54.78%
Nxera Pharma Co Ltd 95.29%
PeptiDream Inc 87.73%
Healios KK --

Max Drawdown (5Y) Related Metrics

Alpha (5Y) -13.26
Beta (5Y) 0.3184
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 23.94%
Historical Sharpe Ratio (5Y) -0.3762
Historical Sortino (5Y) -0.6931
Monthly Value at Risk (VaR) 5% (5Y Lookback) 10.52%